WHO ICTRP trial
Comparison of Dexmedetomidine Versus Ketamine-Propofol ?combination versus…
IRCT20141209020258N148 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20141209020258N148 |
|---|---|
| Public title | Comparison of Dexmedetomidine Versus Ketamine-Propofol ?combination versus Propofol for Sedation in Cataract Surgery |
| Scientific title | Comparison of Dexmedetomidine Versus Ketamine-Propofol ?combination versus Propofol for Sedation in Cataract Surgery |
| Primary sponsor | Arak University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 2-3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Cataract. Age-related cataract |
| Interventions | Intervention 1: Intervention group 1: Dexmedetomidine dose of 0.5 microgram in kilogram will injected intravenously to patients in 10 minutes. Intervention 2: Intervention group: 20 milliliter of propofol and 2 milliliter of ketamine and 28… |
| Registration date | Sep 21, 2020 |
| Target size | 96 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: